Insufficient scRNA-seq data for expression of PYDC1 at single-cell level.
Insufficient scRNA-seq data for expression of PYDC1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 76% | 196.72 | 2013 / 2642 | 27% | 0.99 | 192 / 705 |
skin | 71% | 278.29 | 1284 / 1809 | 9% | 0.95 | 42 / 472 |
breast | 1% | 0.32 | 3 / 459 | 59% | 34.09 | 663 / 1118 |
tonsil | 0% | 0 | 0 / 0 | 38% | 9.62 | 17 / 45 |
thymus | 0% | 0 | 0 / 653 | 16% | 2.13 | 96 / 605 |
uterus | 0% | 0 | 0 / 170 | 15% | 2.22 | 70 / 459 |
lung | 0% | 0 | 0 / 578 | 15% | 1.47 | 171 / 1155 |
prostate | 2% | 0.76 | 4 / 245 | 12% | 0.27 | 58 / 502 |
esophagus | 0% | 0 | 0 / 1445 | 13% | 0.80 | 23 / 183 |
bladder | 0% | 0 | 0 / 21 | 12% | 0.48 | 62 / 504 |
ovary | 0% | 0 | 0 / 180 | 12% | 0.44 | 51 / 430 |
intestine | 0% | 0 | 0 / 966 | 11% | 0.42 | 58 / 527 |
lymph node | 0% | 0 | 0 / 0 | 10% | 0.16 | 3 / 29 |
pancreas | 0% | 0 | 0 / 328 | 10% | 0.22 | 17 / 178 |
adrenal gland | 0% | 0.31 | 1 / 258 | 9% | 0.66 | 20 / 230 |
stomach | 0% | 0 | 0 / 359 | 9% | 0.26 | 25 / 286 |
kidney | 0% | 0 | 0 / 89 | 9% | 1.80 | 78 / 901 |
liver | 0% | 0 | 0 / 226 | 8% | 0.80 | 34 / 406 |
muscle | 5% | 2.85 | 42 / 803 | 0% | 0 | 0 / 0 |
adipose | 0% | 0.10 | 1 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 0.22 | 1 / 1335 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0032731 | Biological process | positive regulation of interleukin-1 beta production |
GO_2000660 | Biological process | negative regulation of interleukin-1-mediated signaling pathway |
GO_0010804 | Biological process | negative regulation of tumor necrosis factor-mediated signaling pathway |
GO_0043124 | Biological process | negative regulation of canonical NF-kappaB signal transduction |
GO_0032691 | Biological process | negative regulation of interleukin-1 beta production |
GO_1900226 | Biological process | negative regulation of NLRP3 inflammasome complex assembly |
GO_0032088 | Biological process | negative regulation of NF-kappaB transcription factor activity |
GO_0045087 | Biological process | innate immune response |
GO_0008385 | Cellular component | IkappaB kinase complex |
GO_0005829 | Cellular component | cytosol |
GO_0005634 | Cellular component | nucleus |
GO_0120283 | Molecular function | protein serine/threonine kinase binding |
GO_0030291 | Molecular function | protein serine/threonine kinase inhibitor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | PYDC1 |
Protein name | Pyrin domain-containing protein 1 (PAAD-only protein 1) (Pyrin-only protein 1) (cellular POP1) (cPOP1) |
Synonyms | ASCI ASC2 POP1 PYC1 |
Description | FUNCTION: Associates with PYCARD/ASC and modulates its ability to collaborate with MEFV/pyrin and NLRP3/cryopyrin in NF-kappa-B and pro-caspase-1 activation. Suppresses kinase activity of NF-kappa-B inhibitor kinase (IKK) complex, expression of NF-kappa-B inducible genes and inhibits NF-kappa-B activation by cytokines and LPS. . |
Accessions | ENST00000302964.4 Q8WXC3 |